Livzon Pharmaceutical Group, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100001QV5
HKD
29.20
0.58 (2.03%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
3,185.93
3,107.65
3,335.53
3,400.56
2,953.12
3,046.00
3,281.21
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,185.93
3,107.65
3,335.53
3,400.56
2,953.12
3,046.00
3,281.21
Raw Material Cost
1,183.88
1,067.64
1,146.31
1,240.13
1,097.92
1,094.21
1,130.51
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
14.82
15.07
16.19
15.93
22.00
23.95
25.31
Selling and Distribution Expenses
1,203.05
1,090.37
1,144.94
1,005.12
1,005.73
913.38
1,050.29
Other Expenses
23.99
23.48
18.98
18.83
27.60
21.60
21.72
Total Expenditure (Excl Depreciation)
2,641.62
2,407.93
2,497.24
2,449.48
2,401.64
2,247.56
2,423.32
Operating Profit (PBDIT) excl Other Income
544.3
699.7
838.3
951.1
551.5
798.4000000000001
857.9000000000001
Other Income
0.46
61.16
160.13
119.87
205.95
33.70
82.54
Operating Profit (PBDIT)
572.67
886.66
1,116.95
1,192.35
741.55
916.60
1,055.57
Interest
14.82
15.07
16.19
15.93
22.00
23.95
25.31
Exceptional Items
16.85
11.36
-9.47
0.88
-10.75
14.03
-21.52
Gross Profit (PBDT)
2,002.05
2,040.01
2,189.22
2,160.43
1,855.20
1,951.79
2,150.70
Depreciation
171.72
171.06
169.06
167.53
155.42
156.38
183.41
Profit Before Tax
402.98
711.89
922.23
1,009.78
553.38
750.29
825.32
Tax
92.93
97.69
131.57
165.67
156.48
112.37
135.30
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
295.23
516.86
695.27
680.75
419.99
545.99
607.92
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
295.23
516.86
695.27
680.75
419.99
545.99
607.92
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
12.76
115.85
111.35
178.48
-32.20
97.32
81.47
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
308.00
632.71
806.63
859.23
387.79
643.31
689.40
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.11
1.09
1.1
1.07
1.06
1.11
1.07
Reserves
15,468.48
15,261.26
14,984.30
15,198.23
14,752.46
15,674.93
14,956.98
Earnings per share (EPS)
0.33
0.59
0.79
0.76
0.46
0.59
0.66
Diluted Earnings per share
0.33
0.59
0.79
0.76
0.46
0.59
0.66
Operating Profit Margin (Excl OI)
12.57%
21.06%
23.62%
26.61%
12.87%
23.85%
24.06%
Gross Profit Margin
18.04%
28.41%
32.72%
34.62%
24.0%
29.77%
30.74%
PAT Margin
9.27%
16.63%
20.84%
20.02%
14.22%
17.92%
18.53%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Dec 2025 is 7.88% vs -1.55% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Dec 2025 is -20.58% vs 31.28% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is 6.83% vs 13.57% in Dec 2024

stock-summary

Interest

YoY Growth in quarter ended Dec 2025 is -32.73% vs -25.68% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024

Compare Quarterly Results Of Livzon Pharmaceutical Group, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
3,185.93
0
3,185.93
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,185.93
0
3,185.93
Raw Material Cost
1,183.88
0
1,183.88
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
14.82
0
14.82
Selling and Distribution Expenses
1,203.05
0
1,203.05
Other Expenses
23.99
0.00
23.99
Total Expenditure (Excl Depreciation)
2,641.62
0
2,641.62
Operating Profit (PBDIT) excl Other Income
544.31
0.00
544.31
Other Income
0.46
0
0.46
Operating Profit (PBDIT)
572.67
0
572.67
Interest
14.82
0
14.82
Exceptional Items
16.85
0
16.85
Gross Profit (PBDT)
2,002.05
0
2,002.05
Depreciation
171.72
0
171.72
Profit Before Tax
402.98
0
402.98
Tax
92.93
0
92.93
Provisions and contingencies
0
0
0.00
Profit After Tax
295.23
0
295.23
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
295.23
0
295.23
Share in Profit of Associates
0
0
0.00
Minority Interest
12.76
0
12.76
Other related items
0.00
0.00
0.00
Consolidated Net Profit
308.00
0
308.00
Equity Capital
0
0
0.00
Face Value
1.11
0
0.00
Reserves
15,468.48
0
15,468.48
Earnings per share (EPS)
0.33
0
0.33
Diluted Earnings per share
0.33
0
0.33
Operating Profit Margin (Excl OI)
12.57%
0%
0.00
12.57%
Gross Profit Margin
18.04%
0%
0.00
18.04%
PAT Margin
9.27%
0%
0.00
9.27%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 318.59 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 2.52% vs -6.83% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 7.88% vs -1.55% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 30.80 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -51.32% vs -21.56% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -20.58% vs 31.28% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 57.22 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -30.68% vs -13.72% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 6.83% vs 13.57% in Dec 2024

Quarterly - Interest
Interest 1.48 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -1.99% vs -6.79% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -32.73% vs -25.68% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.57%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024